Stoke Therapeutics, Inc. (STOK) shares outstanding

Shares outstanding · fiscal 2025
59.22M

Stoke Therapeutics, Inc. (STOK) had 59.22M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 9.6% higher than the 54.01M of fiscal 2024. Figures as of 18 Nov 2026, 11:40 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
59.22M
Change on fiscal 2024
+9.6%
Highest on record
59.22Mfiscal 2025
Lowest on record
36.74Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Stoke Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 65.41M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 59.22M in fiscal 2025 and the lowest 36.74M in fiscal 2021.

History · 5 fiscal years

Shares outstanding by fiscal year

Stoke Therapeutics, Inc. shares outstanding, year by year

Stoke Therapeutics, Inc. (STOK) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202559.22M 9.6% up
202454.01M 22.8% up
202343.99M 13.1% up
202238.90M 5.9% up
202136.74M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on STOK

Stoke Therapeutics, Inc., figure by figure

Stoke Therapeutics, Inc. (STOK) overview: price, valuation and scorecard

Stoke Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Stoke Therapeutics, Inc. have?

Stoke Therapeutics, Inc. (STOK) had 59.22M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 9.6% higher than the 54.01M of fiscal 2024. The market data feed counts 65.41M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Stoke Therapeutics, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was 59.22M in fiscal 2025 and the lowest 36.74M in fiscal 2021.

How is Stoke Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Stoke Therapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Stoke Therapeutics, Inc. (STOK) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/STOK/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.